Literature DB >> 12087136

Increasing choices for HIV therapy.

Scott M Hammer1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12087136     DOI： 10.1056/NEJM2p020052

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Taking account of future technology in cost effectiveness analysis.

Authors:  Joshua A Salomon; Milton C Weinstein; Sue J Goldie
Journal:  BMJ       Date:  2004-09-25

2.  Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.

Authors:  J Stebbing; S Sawleshwarkar; C Michailidis; R Jones; M Bower; S Mandalia; M Nelson; B Gazzard
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

3.  A single centre cohort experience with a new once daily antiretroviral drug.

Authors:  J Stebbing; M Bower; P Holmes; B Gazzard; M Nelson
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

4.  The Reason for Regimen Change Among HIV/AIDS Patients Initiated on First Line Highly Active Antiretroviral Therapy in Southern Ethiopia.

Authors:  Beharu Woldemedhin; Nasir Tajure Wabe
Journal:  N Am J Med Sci       Date:  2012-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.